Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Translational Research

'Glow in the dark' brains aid tumour surgery

A multi-centre phase II clinical trial for a pioneering new surgical technique has started in the UK.

Cancer Research UK launches groundbreaking research centre at Barts

A new cancer centre, launched today, puts London at the forefront of cancer research.

New technique identifies tumour DNA changes in individual patients

Scientists have developed a new technique that allows them to track the progression of cancer by uncovering changes in their tumour's genetic material.

Gene 'fusion' linked to aggressive brain cancer

A small number of cases of glioblastoma - an aggressive brain tumour - are caused by DNA damage that joins two particular genes together.

CRT and ValiRx sign licensing deal to develop prostate cancer treatment

CANCER RESEARCH TECHNOLOGY has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant...

Cancer Research UK ploughs Ј21 million into new Drug Discovery Programmes

CANCER RESEARCH UK is set to extend its drug discovery effort by investing up to Ј16 million in two new Drug Discovery Programmes at the Paterson Institute for Cancer...

US research suggests prostate drug could prevent cancer

A drug already used to shrink benign, enlarged prostates could also help to reduce the risk of developing prostate cancer.

35 million funding boost for experimental cancer medicine

Cancer Research UK has teamed up with the Departments of Health in England, Scotland, Northern Ireland and Wales to develop and expand a network of Centres for...

Breath test could help to detect cancer

A test using a patient's breath could be developed to detect lung, breast, bowel and prostate cancers, a team of scientists have discovered.

Discovery 'significant step' in understanding leukaemia drug resistance

Scientists have pinpointed an enzyme responsible for breaking down and inactivating a key childhood leukaemia drug, which could help to explain why around 20 per cent of...

Pages